Noteworthy, we set up and fully characterized an in vitro model of insulin resistance developed in cholinergic neurons, to study the underlying molecular events and assess candidate drug, like nerve growth factor (NGF), for counteracting the insulin-resistant state of BFCN. The gene discussed is INS; the disease is Insulin resistance.